Qsemble Capital Management, LP Royalty Pharma PLC Transaction History
Qsemble Capital Management, LP
- $751 Billion
- Q4 2024
A detailed history of Qsemble Capital Management, LP transactions in Royalty Pharma PLC stock. As of the latest transaction made, Qsemble Capital Management, LP holds 180,020 shares of RPRX stock, worth $6.08 Million. This represents 0.61% of its overall portfolio holdings.
Number of Shares
180,020
Previous 39,493
355.83%
Holding current value
$6.08 Million
Previous $1.12 Billion
311.03%
% of portfolio
0.61%
Previous 0.21%
Shares
2 transactions
Others Institutions Holding RPRX
# of Institutions
430Shares Held
294MCall Options Held
508KPut Options Held
118K-
Morgan Stanley New York, NY39.5MShares$1.34 Billion0.07% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.4MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY23MShares$778 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA17MShares$574 Million0.79% of portfolio
-
Baillie Gifford & CO14.1MShares$478 Million0.28% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $14.8B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...